How many investments has Recode Ventures made?

Recode Ventures has 11 tracked investments.

What sectors does Recode Ventures focus on?

Recode Ventures focuses on Digital Health, Healthtech.

Where is Recode Ventures located?

Recode Ventures is headquartered in San Francisco, US.

Who does Recode Ventures co-invest with?

Recode Ventures most often shares deals with Y Combinator, DCVC (Data Collective), Hummingbird Ventures, among 35 tracked co-investors.

Recode Ventures

Venture capital

San Francisco · 8 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Recode Ventures

5,875 people in our graph share verified history with the Recode Ventures team — schools, employers, funds. One of them is your warm intro.

Alan Abbottunlockedknows Armen A. Vidian · together at Stanford University

×4knows the team · via Massachusetts Institute of Technology

×7knows the team · via Stanford University

✨ Fox Verdict

Investment thesis

Recode Ventures believes that exponential technologies are transforming healthcare, and technology-native founders have an opportunity to apply rapid innovation to modernize an industry still relying on decades-old approaches. The firm's investment thesis is grounded in deep operational experience across the healthcare technology value chain, from early-stage ideation through regulatory approval, public markets, and strategic exits.

Invests inDigital Health Healthtech San Francisco

Source: firm website, verified Aug 6, 2026.

San Francisco, CA, US

Instruments

Equity

Tracked investments

Team · 8 people

from the firm's website & public directories

Vishal Gulati· Founder & Managing Partner

Co-founder of Recode Ventures with nearly three decades of experience as a physician-scientist and venture capitalist. He has backed over 40 companies developing treatments for unmet medical needs and is recognized for early investments in genomics, computational biology, and imaging combined with machine learning. His medical training from Oxford and Imperial College informs his technology assessment capabilities.

Armen A. Vidian· Founder and Managing Partner· San Francisco, Californiain 𝕏

Co-founder with nearly 30 years as an engineer, entrepreneur, and investor focused on healthcare and technology. Previously co-founded BlueTalon (acquired by Microsoft) and was an early partner at DCVC, where he led investments in AI-enabled healthcare and life science companies. He holds degrees in mechanical engineering from MIT and management science from Stanford.

Baroness Nicola Blackwood· Equity Partner

Leader in science and entrepreneurship serving as Chair of Genomics England and Oxford University Innovation, and as a board member of BioNTech. Former UK Minister for Innovation in the Department for Health and Social Care, overseeing life sciences, NHS data, and digital transformation. Member of the House of Lords and the Royal Society Science Policy Expert Advisory Committee.

Jeff Berkowitz· Equity Partner· New York City Metropolitan Areain

Healthcare executive with extensive experience across the global healthcare supply chain, including roles as Executive Vice President at UnitedHealth Group/Optum, President of Pharma and Global Market Access at Walgreens Boots Alliance, and senior vice president of global market access at Merck. Currently CEO of Real Endpoints, a firm focused on pharmaceutical access and market dynamics.

Sir Bruce Keogh· Equity Partner

Distinguished cardiac surgeon and former Medical Director of the NHS and Director General of the Department of Health (2007-2018), where he led clinical policy and strategy. He was knighted in 2003 for services to medicine and has been ranked as the most influential clinician in the NHS. Currently chairs the Birmingham Women's and Children's NHS Foundation Trust.

Tim Garnett· Equity Partner· Chicago, Illinois, United Statesin

Veteran of the pharmaceutical industry with over 20 years at Eli Lilly, including service as Chief Medical Officer from 2008 to 2021. He led development of therapeutics in women's health, endocrinology, and neuroscience through regulatory approval and global launch. Holds medical qualifications and fellowships in pharmaceutical medicine and obstetrics/gynaecology.

Julie Norledge· Executive Assistant

Executive Assistant and Office Manager at Recode since 2022 with over two decades of experience supporting founders and entrepreneurs in diverse industries including film and television production, legal, and luxury retail. She provides administrative and back-office organization.

Lloyd Appel· CFO· United Statesin

CFO with over 30 years of financial management experience at alternative asset firms including hedge funds and venture capital funds. A CPA and CFA who began his career at BDO.

l•••@differential.vcreveal

What they invest in

from 9 of 11 portfolio companies

AI & Machine Learning ×7Biotech ×6Healthtech ×5Deep Tech ×3Digital Health ×3Medical Devices ×3Advanced Manufacturing ×1Enterprise Software ×1

HQs:United States×3United Kingdom×1

Who they back

founder profiles across 5 portfolio companies

27%

repeat founders

of 11 founders with career history

Where their founders worked beforefrom 11 founders with career history

Imperial College London ×3University of Oxford ×2

Accelerator rootsportfolio companies that came through a program

Y Combinator ×3

Investments · 11 tracked

founders shown can be your intro path

By year:2023 · 1 2017 · 12 dated

Caption Carecaption-care.com

Caption Care delivers cardiac ultrasounds (echocardiograms) performed in clinics or patients' homes using AI-guided imaging and interpretation technology, enabling earlier detection of heart disease.

AI & Machine LearningDigital HealthMedical Devices

PartnerArmen A. Vidian· solo GP

Coincidence Labscoincidencelabs.com in

Coincidence Labs builds an AI orchestration layer that connects existing systems and digitizes paper records into a unified data layer, so AI agents can execute time-sensitive tasks like regulatory documentation with human review when needed.

Advanced ManufacturingAI & Machine LearningEnterprise Software

PartnerArmen A. Vidian· solo GP

LabGeniuslabgeni.us in 𝕏Oct 2017

LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.

AI & Machine LearningBiotechDeep TechLondon

Harrison Rickerby(Executive Officer, Director)

BoardJames Field(Executive Officer, Director)in

PartnerArmen A. Vidian· solo GP

Co-investorsAcequia Capital (AceCap)Air Street Capital Backed Beast Ventures Champion Hill Ventures Gigafund +8 more

Nanograbnanograb.com in 𝕏

Nanograb develops gene therapy delivery systems using artificial intelligence to identify peptide-nanoparticle combinations that transport genetic medicines to targeted cells and tissues.

BiotechHealthtechSan Francisco, US

Debesh Mandal(Founder)inChristopher Lau(Founder)inShanil Panara(Founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsSterling Road Y Combinator

PatientGeniepatientgenie.ai

PartnerArmen A. Vidian· solo GP

Persona-Dxpersona-dx.com

PartnerArmen A. Vidian· solo GP

Probably Geneticprobablygenetic.com in 𝕏

Probably Genetic operates a platform for diagnosing genetic diseases, providing comprehensive genetic data and testing to patients and healthcare providers.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Lukas Lange(Founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsAsymmetric Capital Partners Calm/Storm VC Manta Ray Ventures Oxonian Ventures Threshold Ventures Y Combinator +2 more

Propriopropriovision.com in 𝕏

Proprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT.

AI & Machine LearningHealthtechMedical DevicesSeattle, US

Gabriel Jones(Co-founder & CEO)inSamuel Browd(Co-founder)inJoshua Smith(Co-founder)inJames Youngquist(Co-founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsBold Capital Partners Cota Capital DCVC (Data Collective)Bird B. AG HTC Presence Capital +4 more

Sensible Biotechnologiessensible.bio in 𝕏Feb 2023

Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in

BoardVishal Gulati(Director)Joel Schoppig(Director)

PartnerArmen A. Vidian· solo GP

Co-investorsCivilization Ventures Management, Llc KAYA Y Combinator ZAKA VC BlueYard Capital

Verisianverisian.com in 𝕏

Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety.

BiotechDigital HealthHealthtechSaaS

BoardSunil Gupta(Strategic Advisor)

PartnerArmen A. Vidian· solo GP

Co-investorsCambridge Angels group SuperSeed

Waypoint Biowaypointbio.com in 𝕏

Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.

AI & Machine LearningBiotechDeep Tech

Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in

PartnerArmen A. Vidian· solo GP

Co-investorsAmplify Partners Fifty Years Hummingbird Ventures MBX Capital Mitsui Global Investment Amplify Partners CV +2 more

Portfolio news

latest coverage across their companies

Waypoint Bio Raises $20M in Series A Funding

Waypoint Bio · finsmes.com · Jun 2, 2026

Probably Genetic Secures $10.7M Series | Signalbase

Probably Genetic · trysignalbase.com · Mar 24, 2026

Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up Sensible’s Unique Cell-Based mRNA Design and Manufacturing Platform

Sensible Biotechnologies · finance.yahoo.com · Jul 9, 2025

Frequently asked questions

How many investments has Recode Ventures made?: Recode Ventures has 11 tracked investments.
What sectors does Recode Ventures focus on?: Recode Ventures focuses on Digital Health, Healthtech.
Where is Recode Ventures located?: Recode Ventures is headquartered in San Francisco, US.
Who does Recode Ventures co-invest with?: Recode Ventures most often shares deals with Y Combinator, DCVC (Data Collective), Hummingbird Ventures, among 35 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Keynote: Peter Hebert, Lux Capital, and Armen Vidian, Recode Ventures | LSI USA '26

LSI - Life Science Intelligence™ · Armen Vidian

Images

Co-investors · 11

Lux Capital

Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.

Both backed · 2

LabGenius Waypoint Bio

$100K – $100M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

Both backed · 1

Proprio

$5M – $25M

Bold Capital Partners

Bold Capital Partners is a venture capital firm based in Los Angeles, California. Its portfolio includes companies such as Insilico Medicine, which applies artificial intelligence to biomarker development and drug discovery, reflecting a focus on frontier technologies in areas like AI-driven life sciences.

Both backed · 1

Proprio

SuperSeed

SuperSeed is a seed-stage venture capital firm that invests in software startups, typically supporting companies through their initial growth phase toward £1m in revenue. The firm provides capital and operational guidance to early-stage founders.

Both backed · 1

Verisian

$127K – $635K

Bling Capital

Bling Capital is a seed-stage venture firm that backs entrepreneurs seeking to find and scale product-market fit, supported by its Bling Product Council of over 100 product leaders.

$1M – $5M

UpHonest Capital

UpHonest Capital is a Silicon Valley-based investment firm founded in 2017 that supports cross-border entrepreneurship and investment between China and the United States, and runs media, scout, and incubation programs.

$50K – $1M

IA Ventures

IA Ventures is a venture capital firm that invests in early-stage software and frontier technology companies.

$1M – $3M

Passion Capital

Passion Capital is a UK-based early-stage venture firm founded in 2011 by Stefan Glaenzer, Eileen Burbidge, and Robert Dighero, focusing on digital media and technology investments. The founding partners bring combined experience from entrepreneurial and executive roles in technology companies.

Artis Ventures

Artis Ventures is a venture capital firm focused on supporting founders reimagining the systems that sustain life, spanning from cellular biology to broader societal impact.

$50K – $25M

Molten Ventures

Molten Ventures is a European venture capital firm that backs technology founders from Series A onward, providing capital along with expertise and networks to help companies scale globally.

$2.5M – $63M

Foresite Capital

Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.

Firms observed investing alongside Recode Ventures, from public investor directories. Shared companies are the overlap with Recode Ventures's recorded portfolio.

Similar investors

8VC

8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.

$100K – $50M

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Balderton Capital

Balderton Capital is a European venture capital firm that backs technology startups.

$5M – $50M

Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

$5M – $100M